ShockWave Medical, Inc. (SWAV)
NASDAQ: SWAV · IEX Real-Time Price · USD
329.00
+1.48 (0.45%)
At close: Apr 19, 2024, 4:00 PM
328.14
-0.86 (-0.26%)
After-hours: Apr 19, 2024, 7:12 PM EDT

ShockWave Medical Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017
Cash & Equivalents
328.42156.5989.2150.42139.0539.6451.92
Short-Term Investments
662.13147.91111.77151.9356.301.81
Cash & Cash Equivalents
990.55304.49200.98202.35195.3539.6453.73
Cash Growth
225.31%51.50%-0.68%3.59%392.77%-26.22%-
Receivables
114.5571.3737.4411.697.382.850.64
Inventory
107.5975.1142.9829.8612.075.132.52
Other Current Assets
12.578.294.512.41.91.110.97
Total Current Assets
1,225459.26285.9246.3216.748.7457.86
Property, Plant & Equipment
98.6380.5251.8623.9313.742.621.37
Long-Term Investments
1.643.515.990000
Goodwill and Intangibles
132.43000000
Other Long-Term Assets
108.61102.81.941.811.512.070.07
Total Long-Term Assets
341.3186.8359.7825.7415.244.691.45
Total Assets
1,567646.09345.68272.04231.9453.4259.3
Accounts Payable
8.876.723.521.472.791.491.15
Current Debt
005.53.36.671.670
Other Current Liabilities
95.3456.6542.6120.8214.556.223.39
Total Current Liabilities
104.2163.3751.6325.5824.019.374.54
Long-Term Debt
766.9759.1339.9520.8115.2813.380
Other Long-Term Liabilities
26.7212.2712.27000.450.59
Total Long-Term Liabilities
793.6871.452.2220.8115.2813.830.59
Total Liabilities
897.89134.77103.8546.3939.2923.25.13
Total Debt
766.9759.1345.4524.1121.9415.050
Debt Growth
1197.17%30.09%88.54%9.86%45.81%--
Retained Earnings
110.47-36.81-252.81-243.67-177.97-126.87-85.76
Comprehensive Income
0.29-0.87-0.20.010.040-0
Shareholders' Equity
668.68511.32241.83225.65192.65-122.59-83.29
Net Cash / Debt
223.59245.37155.53178.25173.4124.5953.73
Net Cash / Debt Growth
-8.88%57.76%-12.74%2.79%605.10%-54.23%-
Net Cash Per Share
5.856.484.435.397.2514.0034.59
Working Capital
1,121395.89234.27220.72192.6939.3753.32
Book Value Per Share
18.2214.246.896.828.06-69.77-53.62
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).